Day 3 at Neuroscience 2013: Spotlight on Experimental Autism Treatments
Autism Speaks Launches Preclinical Autism Consortium for Therapeutics
NIH Grant Worth Up to $10 Million Will Advance Potential Fragile X Treatment
Autism Speaks Approves New Round of High-Priority Research Projects
Arbaclofen’s Promise and Heartbreak
The experimental autism medicine arbacl... More...
Early Results from Autism Study: Arbaclofen May Improve Sociability
Ten Important Things We Know About Autism Today – That We Didn’t Know a Year Ago
Thanks to your support, research i... More...
New Science, Fresh Hope for Autism
[ Canada | Middle East | 한국어 | En Español | Privacy | Terms of Service | State Fundraising Notices |
Community Guidelines | Affiliate Program | Contact Us | Site Map | Employees | RSS ]
© 2013 Autism Speaks Inc. Autism Speaks and Autism Speaks It's Time To Listen & Design are registered trademarks owned by Autism Speaks Inc. All rights reserved.